TRIM39 is a poor prognostic factor for patients with estrogen receptor‐positive breast cancer and promotes cell cycle progression

Tripartite motif (TRIM) family proteins are involved in various biological processes and the pathophysiology of cancers. However, the roles of TRIM39, a TRIM family member, in breast cancer is not well‐understood. Here, we performed immunohistochemical study of TRIM39 protein in clinical estrogen re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology international 2022-02, Vol.72 (2), p.96-106
Hauptverfasser: Ogura, Takuya, Azuma, Kotaro, Takeiwa, Toshihiko, Sato, Junichiro, Kinowaki, Keiichi, Ikeda, Kazuhiro, Kawabata, Hidetaka, Inoue, Satoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Tripartite motif (TRIM) family proteins are involved in various biological processes and the pathophysiology of cancers. However, the roles of TRIM39, a TRIM family member, in breast cancer is not well‐understood. Here, we performed immunohistochemical study of TRIM39 protein in clinical estrogen receptor‐positive (ER+) breast cancer tissues from 108 patients. TRIM39 immunoreactivity (IR) was positively correlated with advanced stage (p 
ISSN:1320-5463
1440-1827
DOI:10.1111/pin.13190